TABLE 5.
Primer | Primer sequence (5′–3′)a | Amplicon | Amplicon size (bp) |
---|---|---|---|
AfpX-derived amplicons | |||
AFPF | AAAAAGCTTTTGTGAAATTGCTGGCTCAG | AFPX17CH | 1,439 |
AFPR | AAAAAGCTTGAATTCGCGTTAGATACCCCCA | ||
AFP15F | CCAAACGGCTTGCACTACCGCGGG | AFPX1516 | 4,539 |
AFP16R | TGAGACTCATGAGGTCAAGCGTTCC | ||
18MFEF | AAACAATTGGGGCATCTCGCCTCATGAGGG | 18MFE | 2,219 |
18MFER | AAACAATTGGCGAGCGATATACTCCAACGC | ||
17BGLF | AAAAGATCTGGGTGGAGCAGCGATAACGCG | 17BGL | 2,329 |
17BGLR | AAAAGATCTGCAGTGCGTCATCCATCGCCTC | ||
Antibiotic cassettes | |||
KNRVF | AAAGATATCGTAAGCCAGTATACACTCCGCTAGCGC | KNRV | 1,201 |
KNRVR | AAAGATATCAGTGTTACAACCAATTAACCAATTC | ||
KNBGLF | AAAAGATCTGTAAGCCAGTATACACTCCGCTAGCGC | KNBGL | 1,201 |
KNBGLR | AAAAGATCTGAGTGTTACAACCAATTAACCAATTC | ||
KNNAEF | AAAGCCGGCTAAGCCAGTATACACTCCGCTAGCGC | KNNAE | 1,201 |
KNNAER | AAAGCCGGCAGTGTTACAACCAATTAACCAATTC | ||
KNMFEF | AAACAATTGTAAGCCAGTATACACTCCGCTAGCGC | KNMFE | 1,201 |
KNMFER | AAACAATTGGAGTGTTACAACCAATTAACCAATTC | ||
SPBGLF | AAAAGATCTATGCCCGTTCCATACAGAAGCT | SPBGL | 1,379 |
SPBGLR | AAAAGATCTGACATTATTTGCCGACTACCT | ||
SPMFEF | AAACAATTGATGCCCGTTCCATACAGAAGCT | SPMFE | 1,379 |
SPMFER | AAACAATTGCGACATTATTTGCCGACTACCT | ||
Primers for validation of homologous recombination | |||
1516F | GAGTCGTTGTTTACAACGCCAGG | 4,814 | |
1516R | GTGCGCATCTGCATTTACCGG | ||
18F | GTTAGATTACTCCCACCTTCCGGATG | 2,441 | |
18R | GATAATTAGACATCCTCGTTCCTC | ||
17F | TTAACCACTTGGGTAACGACCTCC | 2,632 | |
17R | ACTGGTACTGATTGCGGGTCCAAGG | ||
Diagnostic primers | |||
AFP8F | CTGGACATAGCGGGACAGCGCAGCAC | 909 | |
AFP8R | ACTCAGGGTGATACTCTCGCCCG | ||
AFPX17F | GCCGACTAACACACCACAGTTACAGC | 2,600 | |
AFPX17R | TTAACGCATGATCATTTGCGCTTCCGG | ||
AFPX18F | CAACTGGAGCAGTTCGAGCTGGC | 805 | |
AFPX18R | GTCATAAGACTCATGCCAAGAGTC | ||
REPA | TGCAGGGGAACGATCTTCTTGAGG | 893 | |
REPR | GCCCCACTTTCTTGTACCATCCAG | ||
BOXA1R | CTACGGCAAGGCGACGCTGACG |
Underlining denotes the restriction enzyme site.